Re: A bio investor must

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: A bio investor must

in response to

Re: A bio investor must

rocketman2

posted on Mar 05, 2024 11:24AM

"Zenith had a nice bump today"

That was short lived. I'll be impressed & start getting a little more excited when millions of shares start moving constantly above .50 - $1.00 US or higher.